A 55-year-old with newly diagnosed chronic myeloid leukaemia is considered for first-line treatment. Which therapy does NICE recommend...

Question

A 55-year-old with newly diagnosed chronic myeloid leukaemia is considered for first-line treatment. Which therapy does NICE recommend

Accepted Answer

Imatinib (tyrosine kinase inhibitor)

Answer

High-dose chemotherapy plus autologous transplant

Answer

Hydroxyurea monotherapy

Answer

Supportive care only

Answer

Interferon-alpha only

MCQ (SBA): Chronic myeloid leukaemia